Ikris Pharma International take pride in facilitation of services namely;
Managed Access Program
Clinical Trials Supply
Reference listed drugs sourcing
Good distribution practices
Ikris Pharma International supply innovator drugs/comparator drugs/ RLD for bioequivalence study/ clinical trials from the U.S, EU, UK, Australia, Canada, Brazil, Japan and other countries worldwide.
Ikris Pharma International (IPI) facilitates patients in accessing medicines and other pharmaceutical products unavailable in their home country against valid prescriptions in conformity with all local laws and regulations. IPI does not facilitate access of narcotics, sedatives or any other substances prohibited by the local laws.
Ikris Pharma International do not manufacture any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by our suppliers are owned by their respective manufacturers or licensees.
Ikris Pharma International facilitates patients in accessing medicines and other pharmaceutical products unavailable in their home country against valid prescriptions in conformity with all local laws and regulations. Read More
The term “Managed Access Program” refers to the authorized programs which allow patients access to hard-to-access medicines.Read More
A Reference Listed Drug is an approved drug product to which new generic versions are compared to show that they are bioequivalent.Read More
Good distribution practices ensure maintaining product safety and quality during distribution across the supply chain and this practice is of significant..Read More
Ikris Pharma International is a global service
accessibility to a wide range of pharmaceutical products to the patients, distributors
and healthcare sector. We are amongst the leading pharmaceutical wholesalers in Belgium
having a wide network to supply specialty medicines across the globe under compliant
regulations. As a distributor of pharmaceuticals our highest priority is to maintain
high quality standards throughout the supply chain. Our processes and procedures are
executed under the EU guidelines on Good Distribution Practices of medicinal products
for the human use. Besides that, providing consistent customer services and maintaining
client anonymity are amongst our other top priorities.
By securing medicines through authentic sources, we contribute to the safety and reliability for the patients needing such medicines.
1. Specialty Medicine
2. Unlicensed medicine – Doctors prescribe unlicensed / off labelled prescription medicine when there is no suitable or licensed medicine which meet patient’s requirement.
3. Generic medicine
4. Off labeled prescription medicine